Literature DB >> 11897663

Plk1 promotes nuclear translocation of human Cdc25C during prophase.

Fumiko Toyoshima-Morimoto1, Eri Taniguchi, Eisuke Nishida.   

Abstract

The nuclear accumulation of active M-phase promoting factor (MPF) during prophase is thought to be essential for coordinating M-phase events in vertebrate cells. The protein phosphatase Cdc25C, an activator of MPF, enters the nucleus to keep MPF active in the nucleus during prophase. However, the molecular mechanisms that control nuclear translocation of Cdc25C during prophase are unknown. We show that phosphorylation of a serine residue (Ser198) in a nuclear export signal sequence of human Cdc25C occurs during prophase and promotes nuclear localization of Cdc25C. We also show that Polo-like kinase 1 (Plk1) is responsible for this phosphorylation and that constitutively active Plk1 promotes nuclear localization of Cdc25C. Remarkably, a mutant Cdc25C in which Ser198 is replaced by alanine remains in the cytoplasm when wild-type Cdc25C accumulates in the nucleus during prophase. These results suggest that Plk1 phosphorylates Cdc25C on Ser198 and regulates nuclear translocation of Cdc25C during prophase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897663      PMCID: PMC1084057          DOI: 10.1093/embo-reports/kvf069

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  40 in total

Review 1.  Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C.

Authors:  C G Takizawa; D O Morgan
Journal:  Curr Opin Cell Biol       Date:  2000-12       Impact factor: 8.382

Review 2.  Mitotic kinases as regulators of cell division and its checkpoints.

Authors:  E A Nigg
Journal:  Nat Rev Mol Cell Biol       Date:  2001-01       Impact factor: 94.444

3.  Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase.

Authors:  M S Chen; J Hurov; L S White; T Woodford-Thomas; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

4.  Periodic changes in phosphorylation of the Xenopus cdc25 phosphatase regulate its activity.

Authors:  T Izumi; D H Walker; J L Maller
Journal:  Mol Biol Cell       Date:  1992-08       Impact factor: 4.138

5.  Regulation of the cdc25 protein during the cell cycle in Xenopus extracts.

Authors:  A Kumagai; W G Dunphy
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

Review 6.  Cyclins and their partners: from a simple idea to complicated reality.

Authors:  T Hunt
Journal:  Semin Cell Biol       Date:  1991-08

Review 7.  Universal control mechanism regulating onset of M-phase.

Authors:  P Nurse
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

8.  Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase.

Authors:  F Toyoshima-Morimoto; E Taniguchi; N Shinya; A Iwamatsu; E Nishida
Journal:  Nature       Date:  2001-03-08       Impact factor: 49.962

9.  Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding.

Authors:  P R Graves; C M Lovly; G L Uy; H Piwnica-Worms
Journal:  Oncogene       Date:  2001-04-05       Impact factor: 9.867

10.  Combinatorial control of cyclin B1 nuclear trafficking through phosphorylation at multiple sites.

Authors:  J Yang; H Song; S Walsh; E S Bardes; S Kornbluth
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

View more
  106 in total

Review 1.  Prophase I arrest and progression to metaphase I in mouse oocytes: comparison of resumption of meiosis and recovery from G2-arrest in somatic cells.

Authors:  Petr Solc; Richard M Schultz; Jan Motlik
Journal:  Mol Hum Reprod       Date:  2010-05-07       Impact factor: 4.025

2.  Female infertility in PDE3A(-/-) mice: polo-like kinase 1 (Plk1) may be a target of protein kinase A (PKA) and involved in meiotic arrest of oocytes from PDE3A(-/-) mice.

Authors:  Weixing Shen; Faiyaz Ahmad; Steven Hockman; John Ma; Hitoshi Omi; Nalini Raghavachari; Vincent Manganiello
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

3.  Chemical visualization of phosphoproteomes on membrane.

Authors:  Anton Iliuk; X Shawn Liu; Liang Xue; Xiaoqi Liu; W Andy Tao
Journal:  Mol Cell Proteomics       Date:  2012-05-16       Impact factor: 5.911

Review 4.  Modulation of cell cycle control during oocyte-to-embryo transitions.

Authors:  Eva Hörmanseder; Thomas Tischer; Thomas U Mayer
Journal:  EMBO J       Date:  2013-07-26       Impact factor: 11.598

Review 5.  Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Nat Rev Mol Cell Biol       Date:  2013-09       Impact factor: 94.444

6.  Calcium-dependent inhibition of polo-like kinase 3 activity by CIB1 in breast cancer cells.

Authors:  Meghna U Naik; Ngoc T Pham; Kristin Beebe; Wei Dai; Ulhas P Naik
Journal:  Int J Cancer       Date:  2011-02-01       Impact factor: 7.396

7.  Deregulation of vital mitotic kinase-phosphatase signaling in hematopoietic stem/progenitor compartment leads to cellular catastrophe in experimental aplastic anemia.

Authors:  Ritam Chatterjee; Sukalpa Chattopadhyay; Sujata Law
Journal:  Mol Cell Biochem       Date:  2016-09-08       Impact factor: 3.396

8.  The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex.

Authors:  Kin-Yip Cheng; Edward D Lowe; John Sinclair; Erich A Nigg; Louise N Johnson
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

9.  Multiplexed random peptide library and phospho-specific antibodies facilitate human polo-like kinase 1 inhibitor screen.

Authors:  Kenji Tanaka; Mitsunori Koresawa; Masato Iida; Kazuhiro Fukasawa; Erica Stec; Jason Cassaday; Peter Chase; Keith Rickert; Peter Hodder; Toshimitsu Takagi; Hideya Komatani
Journal:  Assay Drug Dev Technol       Date:  2010-02       Impact factor: 1.738

10.  M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.

Authors:  Nobumoto Watanabe; Harumi Arai; Yoshifumi Nishihara; Makoto Taniguchi; Naoko Watanabe; Tony Hunter; Hiroyuki Osada
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.